Edition:
United States

Biopharmx Corp (BPCG.F)

BPCG.F on Frankfurt Stock Exchange

0.23EUR
13 Oct 2017
Change (% chg)

€-0.01 (-2.55%)
Prev Close
€0.23
Open
€0.22
Day's High
€0.24
Day's Low
€0.22
Volume
5,600
Avg. Vol
2,102
52-wk High
€0.77
52-wk Low
€0.21

Select another date:

Thu, Oct 19 2017

BRIEF-Biopharmx files for offering ‍​of up to $40.3 mln of shares of common stock

* Biopharmx Corp files for offering ‍​of up to $40.3 million of shares of common stock - SEC filing Source text: [http://bit.ly/2l2DwCb] Further company coverage:

BRIEF-BioPharmx Q2 loss per share $0.05

* Q2 earnings per share view $-0.06 -- Thomson Reuters I/B/E/S

BRIEF-Biopharmx to present phase 2B clinical trial data

* Biopharmx to present phase 2B clinical trial data at national DEF essential resource meeting 2017 Source text for Eikon: Further company coverage:

BRIEF-BioPharmx Q1 non-GAAP loss per share $0.07 excluding items

* Q1 earnings per share view $-0.07 -- Thomson Reuters I/B/E/S

BRIEF-Biopharmx says achieved primary endpoint in trial of treatment for acne

* Biopharmx Corp says achieved primary endpoint in its phase 2b clinical trial evaluating bpx-01

BRIEF-Biopharmx announces $5 million offering

* Biopharmx Corp says net proceeds of offering will be used to advance Biopharmx dermatology-focused drug delivery and clinical programs

Select another date: